September 2, 2022
To further strengthen Cambio’s transformation to become the leading platform supplier within eHealth, Ingrid Wistrand has been appointed Chief Product Officer starting end-September 2022.
Before joining Cambio, Ingrid was Vice President of Business Strategy Execution in Deutsche Telekom Internet of Things (IoT). She was responsible for setting the strategy, driving execution, and transforming DT into a global leader in IoT. Ingrid has spent 25 years working with strategy, execution, commercial management, product management, business development, and organisational development in Sweden and internationally. Through her work with IoT, Ingrid has acquired broad digitalisation experience across multiple industries, including healthcare.
We are happy to welcome Ingrid to Cambio. Ingrid is a solid addition to the Cambio team in terms of her leadership, experience driving product organisations and extensive experience driving growth and transformation. Best-in-class products are pivotal to reaching our vision. I am confident that Ingrid will be a key player in contributing to even greater customer value.
Rami Avidan, CEO at Cambio
Cambio is one of the leaders driving digitalisation in health and social care. I am excited to join the team. Building upon the competence and knowledge of the Cambio team, I look forward to this journey driving transformation in health and social care and creating long-term sustainable solutions for our customers.
Ingrid Wistrand will be integral in driving the next phase of Cambio’s growth journey by leading the Product Division and executing Cambio’s ambitious product vision, strategy, and roadmap.
Current Chief Product Officer, Johanna Hultcrantz, will take on a newly established role as Chief Innovation Officer driving innovation with a focus on future value for Cambio’s customers. With her extensive domain expertise within eHealth, Johanna will ensure that Cambio will continue to maintain a forward-leaning position in the critical transformation of health and social care.